1. miR-495 inhibits the growth of fibroblasts in hypertrophic scars
   Bingyu Guo et al, 2019, Aging CrossRef
2. Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia
   Christos Tziotzios et al, 2017, Journal of Investigative Dermatology CrossRef
3. Advancements in Regenerative Strategies Through the Continuum of Burn Care
   Randolph Stone II et al, 2018, Frontiers in Pharmacology CrossRef
4. Extracellular Matrix and Other Factors that Impact on Cutaneous Scarring
   Ruilong Zhao et al, 2018, Chronic Wounds, Wound Dressings and Wound Healing CrossRef
5. Non‐coding RNA and cholesteatoma
   Ivan Jovanovic et al, 2022, Laryngoscope Investigative Otolaryngology CrossRef
6. MiR-375 and miR-5691 exert anti-fibroproliferative effects on hypertrophic scar fibroblasts by suppressing thrombospondin 1 expression
   Jing Lv et al, 2022, Dermatologica Sinica CrossRef
7. Cellular and Molecular Mechanisms of Hypertrophic Scarring
   Antoinette T. Nguyen et al, 2020, Total Scar Management CrossRef
8. Non-coding RNAs in hypertrophic scars and keloids: Current research and clinical relevance: A review
   Linlin Su et al, 2024, International Journal of Biological Macromolecules CrossRef
9. Is the future scarless? – Fibroblasts as targets for scarless wound healing: a narrative review
   Dylan Parry et al, 2022, Scars, Burns & Healing CrossRef
10. Reviewing the Regulators of COL1A1
    Hanne Devos et al, 2023, International Journal of Molecular Sciences CrossRef
11. Decreased expression of microRNA‑145 promotes the biological functions of fibroblasts in hypertrophic scar tissues by upregulating the expression of transcription factor SOX‑9
    Shoujie Wang et al, 2019, Experimental and Therapeutic Medicine CrossRef
12. Advances in scarless foetal wound healing and prospects for scar reduction in adults
    Jia‐Li Yin et al, 2020, Cell Proliferation CrossRef
13. Identification and functional analysis of a three-miRNA ceRNA network in hypertrophic scars
    Zewei Zhang et al, 2021, Journal of Translational Medicine CrossRef
14. The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes
    Sara Amjadian et al, 2022, Skin Pharmacology and Physiology CrossRef
15. Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21
    Fatemeh Khatami et al, 2021, Carbohydrate Polymers CrossRef
16. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
    Deyu Huang et al, 2019, Food and Chemical Toxicology CrossRef
17. Non-coding RNAs as skin disease biomarkers, molecular signatures, and therapeutic targets
    Andrea Roso-Mares et al, 2023, Human Genetics CrossRef
18. Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars
    Ziying Zhu et al, 2020, Journal of Cellular Physiology CrossRef
19. Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns
    Meilang Xue et al, 2018, Advanced Drug Delivery Reviews CrossRef
20. Long non-coding RNA H19 promotes the proliferation, migration and invasion while inhibits apoptosis of hypertrophic scarring fibroblasts by targeting miR-3187-3p/GAB1 axis
    Mengjing Xiao et al, 2021, Burns CrossRef
21. MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment
    Yan Li et al, 2017, Molecular Diagnosis & Therapy CrossRef